Inflection Point VIII IPO Pricing: $287.5 Million on Nasdaq

Key takeaways

• Inflection Point Acquisition Corp. VIII priced its IPO on August 27, 2026 and closed on August 31 with 28,750,000 units, or $287,500,000.
• The count includes 3,750,000 units from the full exercise of the over-allotment option.
• Each unit has one Class A share and one-third of a warrant exercisable at $11.50. Units trade on Nasdaq as IPHXU.
• The full $287.5 million, including up to $13,687,500 of deferred underwriting discount, sits in a U.S. trust account.

The IPO pricing

Inflection Point VIII, a Miami Beach-based blank-check company, priced its IPO of units at $10.00 on August 27, 2026, with Cohen & Company Capital Markets as sole book-running manager and Academy Securities as co-manager. The units began trading on The Nasdaq Global Market on August 28 under IPHXU. The offering closed on August 31, and underwriters exercised their 3,750,000-unit over-allotment option in full at closing, lifting the deal to 28,750,000 units and gross proceeds of $287,500,000.

The Form S-1 (File No. 333-298162) was first filed on August 10, 2026, which puts the path from first filing to pricing at 17 days. Each unit has one Class A ordinary share and one-third of one redeemable warrant. The shares and warrants are expected to trade separately as IPHX and IPHXW.

Term	Detail
Pricing date	August 27, 2026
Closing date	August 31, 2026
Units	28,750,000 at $10.00
Gross proceeds	$287,500,000
Trust account	$287,500,000
Private warrants	8,000,000 at $1.00

Private placement and trust

At the closing, the company sold 8,000,000 private placement warrants at $1.00 for $8,000,000. The sponsor, Inflection Point Holdings VIII LLC, bought 5,000,000, and Cohen & Company Capital Markets bought 3,000,000. The private warrants can’t be transferred until 30 days after an initial business combination, and the underwriter’s warrants cannot be exercised more than five years from the start of sales in the offering, as FINRA Rule 5110(g)(8) provides. They expire worthless if no deal is completed.

The trust account, held at Continental Stock Transfer & Trust Company, holds $287,500,000, equal to $10.00 per unit, and includes up to $13,687,500 of the underwriters’ deferred discount. Interest may be withdrawn for working capital, subject to an annual cap of $1,000,000 plus rollover of unused amounts, and separately to pay taxes.

Agreements and governance

The underwriting agreement with Cohen & Company Capital Markets is dated August 27, as are the warrant agreement, letter agreement, trust agreement and registration rights agreement. The company also signed a services and indemnification agreement with the sponsor and Inflection Point Asset Management LLC. Its amended and restated memorandum and articles took effect on August 27. The board is split into three classes with staggered terms: Denkin’s term runs to the first annual general meeting, Tannenbaum’s and Liquori’s to the second, and Blitzer’s to the third.

Management and mandate

Michael Blitzer is chairman, Kevin Shannon chief executive officer and Adam Saks chief financial officer. Steven Tannenbaum, William J. Liquori and William Denkin joined the board on August 27 as independent directors. Denkin chairs the audit committee and Tannenbaum chairs the compensation committee. The company plans to pursue a business combination with a North American or European business in disruptive growth sectors, though it may pursue any industry, sector or region.

What it means for IPO watchers

A one-third warrant per unit means fewer warrants for each $10.00 unit than a half-warrant structure would give. The full exercise of the over-allotment option at closing lifted the deal to $287.5 million. The key open question, as with every SPAC, is whether a sponsor can turn a pool of trust cash into an acceptable merger inside the allotted time.